Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs

J. K. Abrams, Philip Johnson, A. Hay-Schmidt, J. D. Mikkelsen, Anantha Shekhar, C. A. Lowry

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the α2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.

Original languageEnglish
Pages (from-to)983-997
Number of pages15
JournalNeuroscience
Volume133
Issue number4
DOIs
StatePublished - 2005

Fingerprint

Arousal
Serotonergic Neurons
Anxiety
Pharmaceutical Preparations
Yohimbine
Caffeine
Serotonin 5-HT2 Receptor Agonists
Purinergic P1 Receptor Antagonists
Tryptophan Hydroxylase
GABA-A Receptors
Prosencephalon
Dorsal Raphe Nucleus
Amygdala
Pharmacology
Staining and Labeling
Neurons
FG 7142

Keywords

  • Anxiety
  • Basolateral amygdala
  • c-Fos
  • Dorsal raphe nucleus
  • Retrograde tracing
  • Serotonin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. / Abrams, J. K.; Johnson, Philip; Hay-Schmidt, A.; Mikkelsen, J. D.; Shekhar, Anantha; Lowry, C. A.

In: Neuroscience, Vol. 133, No. 4, 2005, p. 983-997.

Research output: Contribution to journalArticle

Abrams, J. K. ; Johnson, Philip ; Hay-Schmidt, A. ; Mikkelsen, J. D. ; Shekhar, Anantha ; Lowry, C. A. / Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. In: Neuroscience. 2005 ; Vol. 133, No. 4. pp. 983-997.
@article{af1f1c1f4ae34bc68dde598624f5a1ac,
title = "Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs",
abstract = "Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the α2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.",
keywords = "Anxiety, Basolateral amygdala, c-Fos, Dorsal raphe nucleus, Retrograde tracing, Serotonin",
author = "Abrams, {J. K.} and Philip Johnson and A. Hay-Schmidt and Mikkelsen, {J. D.} and Anantha Shekhar and Lowry, {C. A.}",
year = "2005",
doi = "10.1016/j.neuroscience.2005.03.025",
language = "English",
volume = "133",
pages = "983--997",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs

AU - Abrams, J. K.

AU - Johnson, Philip

AU - Hay-Schmidt, A.

AU - Mikkelsen, J. D.

AU - Shekhar, Anantha

AU - Lowry, C. A.

PY - 2005

Y1 - 2005

N2 - Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the α2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.

AB - Serotonergic systems play important roles in modulating behavioral arousal, including behavioral arousal and vigilance associated with anxiety states. To further our understanding of the neural systems associated with increases in anxiety states, we investigated the effects of multiple anxiogenic drugs on topographically organized subpopulations of serotonergic neurons using double immunohistochemical staining for c-Fos and tryptophan hydroxylase combined with topographical analysis of the rat dorsal raphe nucleus (DR). Anxiogenic drugs with diverse pharmacological properties including the adenosine receptor antagonist caffeine, the serotonin 5-HT2A/2C receptor agonist m-chlorophenyl piperazine (mCPP), the α2-adrenoreceptor antagonist yohimbine, and the benzodiazepine receptor partial inverse agonist N-methyl-beta-carboline-3-carboxamide (FG-7142) induced increases in behavioral arousal and vigilance behaviors consistent with an increase in anxiety state. In addition, these anxiogenic drugs, excluding yohimbine, had convergent actions on an anatomically-defined subset of serotonergic neurons within the middle and caudal, dorsal subdivision of the DR. High resolution topographical analysis revealed that at the mid-rostrocaudal level, caffeine and FG-7142 had convergent effects on c-Fos expression in serotonergic neurons that were restricted to a previously undefined region, which we have named the shell region of the dorsal part of the dorsal raphe nucleus (DRDSh), that overlaps the anatomical border between the dorsal part of the dorsal raphe nucleus, the ventral part of the dorsal raphe nucleus (DRV), and the ventrolateral part of the dorsal raphe nucleus (DRVL). Retrograde tracing methods revealed that DRDSh contains large numbers of neurons projecting to the basolateral amygdaloid nucleus, a forebrain structure important for emotional appraisal and modulation of anxiety-related physiological and behavioral responses. Together these findings support the hypothesis that there is a functional topographical organization in the DR and are consistent with the hypothesis that anxiogenic drugs have selective actions on a subpopulation of serotonergic neurons projecting to a distributed central autonomic and emotional motor control system regulating anxiety states and anxiety-related physiological and behavioral responses.

KW - Anxiety

KW - Basolateral amygdala

KW - c-Fos

KW - Dorsal raphe nucleus

KW - Retrograde tracing

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=20444450115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444450115&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2005.03.025

DO - 10.1016/j.neuroscience.2005.03.025

M3 - Article

C2 - 15916857

AN - SCOPUS:20444450115

VL - 133

SP - 983

EP - 997

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

IS - 4

ER -